Whether the price will ever be reached like this or whether a share split would happen at some point at the price of $LLY (+0.85%)

Eli Lilly
Price
Discussion about LLY
Posts
107NOVO NORDISK LAUNCHES NOVOCARE PHARMACY ON THE MARKET
$HIMS (+5.22%)
$LLY (+0.85%)
$NOVO B (+0.6%)
$NVO (+0.71%)
$NOVO B (+0.6%) introduces NovoCare ® Pharmacy, which lowers the cost of all doses of FDA-approved Wegovy ® (semaglutide) to $499 per month and offers convenient home delivery for cash-paying patients.
While 90% of patients taking Wegovy ® have a co-pay of $0 to $25 per month, this offer was developed to support patients who are self-pay and do not have insurance coverage.

"Safe" shares in uncertain times?
The markets remain volatile and in times of crisis many investors look for stable investments. But which sectors and companies have historically proven to be particularly resilient or could even benefit?
Consumer staples - products that will always be needed
Companies such as Procter & Gamble $PG (-1.02%) Nestlé $NESN (+0.46%) or Coca-Cola $KO (-1.01%) benefit from their strong market position and stable cash flows. People are always buying household products, food and beverages.
Healthcare sector - crisis-resistant growth stocks
Companies such as Johnson & Johnson $JNJ (-0.71%) , Eli Lilly $LLY (+0.85%) or Novo Nordisk $NOVO B (+0.6%) supply medicines and treatments that are in demand regardless of the economic situation. There is a particular focus on the boom in diabetes and obesity therapies.
Providers - Stable income through basic care
Companies such as NextEra Energy $NEE (+0.04%) Duke Energy $DUK (+0.73%) or Southern Company $SO (+0.4%) are benefiting from the constant demand for electricity and water. Renewable energies are also playing an increasingly important role.
Commodities & gold - hedging against inflation & uncertainty
Gold mining companies such as Barrick Gold $ABX (-0.58%) or Newmont $NEM (+0.75%) often benefit in times of economic uncertainty, as investors flee to gold as protection against crises.
Defense & Armaments - Profiteers of geopolitical tensions
Rising military spending worldwide makes companies such as Lockheed Martin $LMT (-1.67%) or Northrop Grumman $NOC (-1.76%) into potential winners of long-term conflicts and global uncertainties.
This is just a small selection of companies. But hopefully it gives a small insight into the interesting crisis-proof sectors.
Defensive investors could now focus on consumer staples, healthcare and utilities for long-term stability. Opportunity-oriented investors could look to commodities, gold or defense if geopolitical tensions continue to rise.
US court finds mass layoffs illegal | Instagram plans Reels app | Eli Lilly invests in US production
US court finds mass dismissals illegal
A US court has ruled that the mass dismissals of probationary employees by the Trump administration were probably unlawful. Judge William Alsup found that the Office of Personnel Management (OPM) had no authority to dismiss employees from other agencies. The decision could have far-reaching implications for some 200,000 probationary employees in the federal service, many of whom are in their first two years on the job. The judge issued a temporary restraining order temporarily halting OPM's orders to terminate employees. The lawsuit was filed by a coalition of unions and nonprofit organizations that argued that the OPM acted unlawfully by misrepresenting employees as underperforming.
Instagram $META (+2.3%) plans Reels app
Instagram is reportedly considering launching its short video feature Reels as a standalone app. This consideration comes amid uncertainty over the future of TikTok in the US. Adam Mosseri, the head of Instagram, informed employees of this possible move. TikTok is under pressure to comply with new legal requirements that could see it forced to sell or be banned. Meta, Instagram's parent company, has not yet responded to an inquiry from the BBC.
Eli Lilly $LLY (+0.85%) invests in US production
Eli Lilly announced that the company will invest USD 50 billion in the construction of three new production facilities in the USA. This initiative is aimed at producing key raw materials for drugs in the US, most of which currently come from abroad. Lilly plans to spend $27 billion to build four new facilities, including those that will produce active pharmaceutical ingredients. The decision comes amid national security concerns about reliance on foreign suppliers. Lilly's CEO Dave Ricks emphasized the need to bring supply chains closer to key markets and asked for government support to speed up approval processes.
Sources:
https://www.bbc.com/news/articles/clydd7zeye7o
https://www.bbc.com/news/articles/cvgwwd09vwzo
https://www.washingtonpost.com/business/2025/02/26/eli-lilly-drug-manufacturing-tariffs-domestic/
Podcast episode 77 "Buy High. Sell Low."
Podcast episode 77 "Buy High. Sell Low."
Subscribe to the podcast to get Novo & AMD back on track.
00:00:00 Novo Nordisk $NVO (+0.71%)
$LLY (+0.85%)
00:26:00 BYD $1211 (+5.43%)
$TSLA (+3.78%)
00:44:30 Nu Holdings $NU (+7.36%)
01:07:00 AMD $AMD (+2.21%)
$NVDA (+4.13%)
$INTC (+0.5%)
01:29:00 Election programs SPD & Greens
Spotify
https://open.spotify.com/episode/5PLVDJVROTrUKYtHMWj2Yz?si=5PvCiTPWRPaYPyQ3XcV-Iw
YouTube
https://youtu.be/Z2WkTM1NB6M?si=gXx_9DWNQpwkbDna
Apple Podcast
Tow ?
Today, Novo N has already come close to resistance twice.
Yesterday had $LLY (+0.85%) delivered similar figures to Novo.
Both shares are moving upwards. Then today more good news from LLY.
My hope is that one will pull the other along and the resistance will therefore not be so strong. After that, things could move quickly.
What do you think?
Trending Securities
Top creators this week